You are here

Article info

Article menu

Download PDFPDF

Translational research biomarkers
65 The prognostic significance of eukaryotic translation initiation factors (eIFs) in ovarian cancer
Free

Authors

  • M Sobočan University Medical Centre Maribor, Division for Gynaecology and Perinatology, Maribor, Slovenia University of Maribor , Faculty of Medicine, Maribor, Slovenia PubMed articlesGoogle scholar articles
  • S Sprung Medical University of Innsbruck, Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck, Austria PubMed articlesGoogle scholar articles
  • C Schatz Medical University of Innsbruck, Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck, Austria PubMed articlesGoogle scholar articles
  • J Knez University Medical Centre Maribor, Division for Gynaecology and Perinatology, Maribor, Slovenia University of Maribor , Faculty of Medicine, Maribor, Slovenia PubMed articlesGoogle scholar articles
  • R Kavalar University of Maribor , Faculty of Medicine, Maribor, Slovenia University Medical Centre Maribor, Department of Pathology, Maribor, Slovenia PubMed articlesGoogle scholar articles
  • I Takač University of Maribor , Faculty of Medicine, Maribor, Slovenia University Medical Centre Maribor, Department of Pathology, Maribor, Slovenia PubMed articlesGoogle scholar articles
  • J Haybaeck Medical University of Innsbruck, Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck, Austria Medical University Graz, Diagnostic and Research Center for Molecular BioMedicine, Department of Neuropathology, Diagnostic and Research Institute of Pathology, Graz, Austria PubMed articlesGoogle scholar articles

Citation

Sobočan M, Sprung S, Schatz C, et al
65 The prognostic significance of eukaryotic translation initiation factors (eIFs) in ovarian cancer
International Journal of Gynecologic Cancer 2021;31:A331.

Publication history

  • First published October 12, 2021.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.